Xenon Pharmaceuticals (XENE) Asset Utilization Ratio (2014 - 2025)

Xenon Pharmaceuticals (XENE) has 10 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.

• On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q4 2025; TTM through Dec 2025 was 0.01, a N/A change from a year earlier, with the FY2025 full-year figure at 0.01, changed N/A from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.01, up from 0.01 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for XENE reached as high as 0.12 in Q1 2021 and fell as low as 0.0 in Q2 2024.
• Historically, Asset Utilization Ratio has averaged 0.03 across 4 years, with a median of 0.01 in 2022.
• Across the five-year window, Asset Utilization Ratio sank 77.41% in 2022 and jumped 7126.86% in 2025, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.04 in 2021, then sank by 72.03% to 0.01 in 2022, then plunged by 98.81% to 0.0 in 2024, then soared by 8155.05% to 0.01 in 2025.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.01 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.